Stock Screener App

Frei -

Installieren

7.79

2.87% -0.23

after-market

Handel nachbörslich: 7.75 -0.04 -0.51%

Biocryst Pharmaceuticals Inc (BCRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Biocryst Pharmaceuticals Inc-Aktie (BCRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	39.53% 218.25	156.41	406.56	159.40	163.35
Cost Of Revenue	28.58% 3.84	5.377	9.522	2.187	2.798
Selling, General, and Administrative	32.34% 63.98	94.55	-	-	-
Costs And Expenses	86.04% 119.78	858.01	146.17	129.80	133.57
Operating Income/Loss	114.03% 98.47	-701.60	260.38	29.59	29.79
Nonoperating Income/Loss	1.14% -18.99	-19.21	-12.37	-17.46	-23.30
Income/Loss From Continuing Operations Before Tax	111.03% 79.47	-720.81	248.02	12.13	6.486
Income Tax Expense/Benefit	7.47% 1.079	1.004	2.172	-0.769	1.401
Net Income/Loss	110.86% 78.39	-721.81	245.84	12.90	5.085
Basic Average Shares	5.05% 254.48	242.26	0.362	210.18	209.52
Diluted Average Shares	9.46% 265.17	242.26	0.232	219.88	219.89
Basic Earnings Per Share	110.40% 0.31	-2.98	1.17	0.06	0.02
Diluted Earnings Per Share	110.07% 0.30	-2.98	1.13	0.06	0.02

TRLV

$10.01

2.82%

XERS

$10.31

2.38%

ALVO

$5.00

5.84%

SUPN

$37.88

4.27%

PRGO

$16.63

0.91%

ANIP

$72.29

0.01%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters